Growth Share Schemes and PDMR Dealing
22 June 2022
Alpha FX Group plc
("Alpha FX" or the "Company")
Growth Share Schemes and PDMR Dealing
Alpha FX Group plc (AIM: AFX), a high-tech, high-touch provider of FX risk management, accounts and payments solutions to corporates and institutions internationally, today wishes to provide an update with regard to changes to the Group's Employee Share Schemes.
Following on from the issuance of the E Share Growth Scheme in 2020, in which a total of 882 E Shares were issued to employees of the Group, the Group will be adopting three new Growth Share Schemes as described below resulting in a total of 910 shares being issued to employees of the Group.
F Share Growth Scheme
The Group will be adopting a growth share scheme, in addition to and on similar terms to the existing C Share Growth Scheme and E Share Growth Scheme under which 285 F ordinary shares ("F Shares") in Alpha FX Limited will be issued to certain employees of the Group ("F Share Growth Scheme").
The F Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in Alpha FX Group plc ("Alpha"). The F Shares will vest in four equal tranches, occurring annually, in respect of the Financial Years for 2023, 2024, 2025 and 2026. Vesting for each Financial Year will require Group revenue growth of 20% in Financial Year 2023, 20% in Financial Year 2024, 20% in Financial Year 2025 and 20% in Financial Year 2026. The rate of conversion that the F Shares will be regarded as worth, is a pro rata share of the market capitalisation gain of Alpha above a hurdle price of £740 million. The gain that an F shareholder could receive is capped through placing a ceiling on the maximum market capitalisation of Alpha of £1,867 million. The result of doing so is that the F Shares will be entitled to a pro rata share of the gain in market capitalisation of Alpha between £740 million and the market capitalisation ceiling of £1,867 million.
Upon conversion, the number of ordinary shares in Alpha that an F Shareholder will receive is such number of ordinary shares whose value is equivalent to Alpha's closing share price at the conversion date. Conversion is only permitted to the extent that the F Shares have vested.
G Share Growth Scheme
The Group will be adopting a new growth share scheme under which 360 G ordinary shares ("G Shares") in Alpha FX Limited will be issued to certain employees ("G Shareholders") of the Group ("G Share Growth Scheme").
The G Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in Alpha FX Group plc. The G Shares will vest in five tranches, occurring annually, in respect of the Financial Years for 2022, 2023, 2024, 2025 and 2026. The G Shareholders will be able to vest 12.5% of their holding for Financial Year 2022, 12.5% for Financial Year 2023, 25% for Financial Year 2024, 25% for Financial Year 2025 and 25% for Financial Year 2026. Vesting for each Financial Year will require revenue from the London Corporate division (and any future corporate division in Spain) to grow by 5.5% in Financial Year 2022, 15% in Financial Year 2023, 15% in Financial Year 2024, 15% in Financial Year 2025 and 15% in Financial Year 2026. The rate of conversion that the G Shares will be regarded as worth, is a pro rata share of the market capitalisation gain of Alpha above a hurdle price of £740 million. The gain that a G shareholder could receive is capped through placing a ceiling on the maximum market capitalisation of Alpha of £1,867 million. The result of doing so is that the G Shares will be entitled to a pro rata share of the gain in market capitalisation of Alpha between £740 million and the market capitalisation ceiling of £1,867 million.
Upon conversion, the number of ordinary shares in Alpha that a G Shareholder will receive is such number of ordinary shares whose value is equivalent to Alpha's closing share price at the conversion date. Conversion is only permitted to the extent that the G Shares have vested.
H Share Growth Scheme
The Group will be adopting a new growth share scheme under which 265 H ordinary shares ("H Shares") in Alpha FX Limited will be issued to certain employees ("H Shareholders") of the Group ("H Share Growth Scheme").
The H Shares contain a put option, such that, when and to the extent vested, they can be converted into ordinary shares in Alpha FX Group plc. The H Shares will vest in five tranches, occurring annually, in respect of the Financial Years for 2022, 2023, 2024, 2025 and 2026. The H Shareholders will be able to vest 12.5% of their holding for Financial Year 2022, 12.5% for Financial Year 2023, 25% for Financial Year 2024, 25% for Financial Year 2025 and 25% for Financial Year 2026. Vesting for each Financial Year is subject to 2 revenue targets being met, with H Shareholders being entitled to vest 50% of their holding for each Financial Year in respect of each target being met. The first revenue target is for the London Corporate division (and any future corporate division in Spain) to grow by 5.5% in Financial Year 2022, 15% in Financial Year 2023, 15% in Financial Year 2024, 15% in Financial Year 2025 and 15% in Financial Year 2026. The second target is for the revenue from all the global corporate divisions to grow by 18.6% in Financial Year 2022, 20% in Financial Year 2023, 20% in Financial Year 2024, 20% in Financial Year 2025 and 20% in Financial Year 2026. The rate of conversion that the H Shares will be regarded as worth, is a pro rata share of the market capitalisation gain of Alpha above a hurdle price of £740 million. The gain that an H shareholder could receive is capped through placing a ceiling on the maximum market capitalisation of Alpha of £1,867 million. The result of doing so is that the H Shares will be entitled to a pro rata share of the gain in market capitalisation of Alpha between £740 million and the market capitalisation ceiling of £1,867 million.
Upon conversion, the number of ordinary shares in Alpha an H Shareholder will receive is such number of ordinary shares whose value is equivalent to Alpha's closing share price at the conversion date. Conversion is only permitted to the extent that the H Shares have vested.
111 of the H Shares are being issued to Alex Howorth, who is a PDMR of the Company, and therefore the relevant regulatory disclosure has been made in the table below.
|
Enquiries:
Alpha FX Group plc |
via Alma PR |
|
Morgan Tillbrook, Founder and CEO |
|
|
Tim Kidd, CFO |
|
|
|
|
|
Liberum Capital Limited (Nominated Adviser and Sole Broker) |
Tel: +44 (0) 20 3100 2000 |
|
Neil Patel |
|
|
Cameron Duncan |
|
|
Kane Collings |
|
|
|
|
|
Alma PR (Financial Public Relations) |
Tel: +44 (0) 20 3405 0205 |
|
Josh Royston |
|
|
Andy Bryant |
|
|
Kieran Breheny |
|
|
1
|
Details of the person discharging managerial responsibilities / person closely associated
|
|||||
|
a)
|
Name
|
Alex Howorth |
||||
|
2
|
Reason for the notification
|
|||||
|
a)
|
Position/status
|
Group Managing Director - FX Risk Management |
||||
|
b)
|
Initial notification /Amendment
|
Initial |
||||
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||
|
a)
|
Name
|
Alpha FX Group plc |
||||
|
b)
|
LEI
|
213800RESM1FPUXY6K31 |
||||
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||
|
a)
|
Description of the financial instrument, type of instrument |
H ordinary shares in Alpha FX Limited, which may be convertible into ordinary shares in Alpha FX Group plc |
||||
|
|
|
|||||
|
Identification code |
ISIN: GB00BF1TM596 |
|||||
|
|
|
|||||
|
b)
|
Nature of the transaction
|
Issue of H Shares |
||||
|
c)
|
Price(s) and volume(s) |
|
|
|
|
|
|
|
|
Price(s) |
Volume(s) |
|
||
|
|
|
N/A |
111 H Shares |
|
||
|
|
|
|
|
|||
|
|
|
|
|
|
||
|
d)
|
Aggregated information |
N/A |
||||
|
|
|
|||||
|
- Aggregated volume |
|
|||||
|
|
|
|||||
|
- Price |
|
|||||
|
|
|
|||||
|
e)
|
Date of the transaction
|
22 June 2022 |
||||
|
f)
|
Place of the transaction
|
Off market |
||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 4 minutes ago British American Tobacco
- 9 minutes ago British American Tobacco
- 13 minutes ago B.P. Marsh & Partners
- 14 minutes ago British American Tobacco
- 31 minutes ago CC Japan Income & Growth Trust